Helping to close the loop on glycaemic control
Kaye is a 60-year-old woman with a highly demanding job as a CEO. She was diagnosed with type 1 diabetes at age 54 and started…
Tag: Diabetes
Doctors reverse type 1 diabetes with stem cell transplant: report
A 25-year-old woman with hard-to-control type 1 diabetes began producing her own insulin just months after an autologous transplant of reprogrammed stem cells. She was…
WHO database ‘shows safety signal’ for semaglutide and suicidal ideation: study
Researchers have called for an urgent assessment of a possible link between semaglutide and suicidality based on a study of a WHO adverse event database.…
Diabetes out of the blue points to a life-changing diagnosis
Keith, a 67-year-old retiree, presents to his GP with several months of weight loss and increased appetite. He is otherwise well with no past medical…
GLP-1 RAs tied to greater risk of diabetic retinopathy progression than SGLT-2is: study
In patients with diabetes and established diabetic retinopathy, treatment with GLP-1 receptor agonists is associated with increased risks of diabetic retinopathy progression compared with SGLT-2…
Maggots succeed after standard wound care fails for diabetic foot ulcer: case study
A longstanding diabetic foot ulcer that had failed to improve with standard wound care finally healed with the aid of maggot therapy, honey dressings and…
A lesson in mealtime carb counting for type 1 diabetes
Josh is a 26-year-old accountant diagnosed with type 1 diabetes six months ago after presenting to hospital with diabetic ketoacidosis. Josh has no other known…
American Diabetes Association’s 84th Scientific Sessions — conference highlights
The annual meeting of the American Diabetes Association was held in Orlando, Florida, last month. The conference — one of the biggest events in the…
GLP-1 RAs slapped with ileus warning after TGA investigation
New safety warnings about the risk of ileus have been added to all GLP-1 receptor agonists following a TGA investigation into local reports of the…
Watch for retained gastric contents with periprocedural GLP-1 RA use: new guidance
Patients taking GLP-1 receptor agonists within four weeks of anaesthesia for non-endoscopic procedures should be considered non-fasted, according to new guidance. Doctors are also advised…
